Preferential repair of the N-ras gene in K 562 cells after exposure to cisplatin

Anti-Cancer Drugs

Volumn 10, Issue 6, 1999, Pages 545-549

  Dempke, Wolfram ^a   Voigt, Wieland ^a   Grothey, Axel ^a   Schmoll, Hans Joachim ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Cisplatin; Gene specific repair; N ras

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; TAQ POLYMERASE;

ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CELL STRAIN K 562; CONTROLLED STUDY; DEFENSE MECHANISM; DNA DAMAGE; DNA REPAIR; DRUG RESISTANCE; HUMAN; HUMAN CELL; ONCOGENE N RAS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RADIATION; SIGNAL TRANSDUCTION;

EID: 0032823625     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199907000-00006     Document Type: Article

References (30)

1. 1. Lochrer PJ, Einhorn LH. Cisplatin. Ann Intern Med 1984; 100: 704-13.
2. 2. Perez RP. Cellular and molecular determinants of cisplatin resistance. Eur J Cancer 1998; 34: 1535-42.
3. 3. Roberts JJ, Knox RJ, Friedlas F, Lydall DA. DNA as the target for the cytotoxic and antitumour action of platinum co-coordination complexes: comparative in vitro and in vivo studies of cisplatin and carboplatin. In: McBrien DCH, Slater TF, eds. Biochemical mechanisms of platinum antitumour drugs. Oxford: IRL Press 1986: 29-64.
4. 4. Eastman A. The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes. Pharmacol Ther 1987; 34: 155-66.
5. 5. Bohr VA. Differential DNA repair within the genome. Cancer Rev 1987; 7: 28-55.
6. 6. Jones JC, Zhen W, Reed E, Parker RJ, Sancar A, Bohr VA. Gene-specific formation and repair of cisplatin intrastrand adducts and interstrand cross-links in chinese hamster ovary cells. J Biol Chem 1991; 266: 7101-7.
7. 7. Zhen W, Link CJ, O'Connor PM, et al. Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell lines. Mol Cell Biol 1992; 12: 3689-98.
8. 8. Petersen LN, Mamenta EL, Stevnser T, Chaney SG, Bohr VA. Increased gene specific repair of cisplatin induced interstrand crosslinks in cisplatin resistant cell lines, and studies on carrier ligand specificity. Carcinogenesis 1996; 17: 2597-602.
9. 9. Culliane C, Bohr VA. DNA interstrand cross-links induced by psoralen are not repaired in mammalian mitochondria. Cancer Res 1998; 58: 1400-4.
10. 10. Govan HL, Valles-Ayoub Y, Braun J. Fine-mapping of DNA damage and repair in specific genomic segments. Nucleic Acids Res 1990; 18: 3823-30.
11. 11. Jennerwein MM, Eastman A. A polymerase chain reaction-based method to detect cisplatin adducts in specific genes. Nucleic Acids Res 1991; 19: 6209-14.
12. 12. McCarthy MJ, Rosenblatt JL, Lloyd RS. Kinetics of repair of UV-induced DNA damage in repair-proficient and -deficient cells as determined by quantitative polymerase chain reaction. Photochem Photobiol 1997; 66: 356-62.
13. 13. Sklar MD. Increased resistance to cis-diamminedichloroplatinum(II) in NIH 3T3 cells transformed by ras oncogenes. Cancer Res 1988; 48: 793-7.
14. 14. Isonishi S, Horn DK, Thiebaut FB, et al. Expression of the c-Ha-ras oncogene in mouse NIH 3T3 cells induces resistance to cisplatin. Cancer Res 1991; 51: 5903-9.
15. 15. Niimi S, Nakagawa K, Yokota J, et al. Resistance to anticancer drugs in NIH3T3 cells transfected with c-myc and/or c-H-ras genes. Br J Cancer 1991; 63: 237-41.
16. 16. Barbacid M. Ras genes. Annu Rev Biochem 1987; 56: 779-827.
17. 17. MacDonald SG, McCormick F. The ras/raf/erk signal transduction pathway. In Peters G, Vousden KH, eds. Oncogenes and tumour suppressors. Oxford: IRL Press 1997: 121-53.
18. 18. Lozzio CB, Lozzio BB. Human chronic myelogeneous leukemia cell-line with positive Philadelphia chromosome. Blood 1975; 45: 321-5.
19. 19. Fichtinger-Schepman AMJ, van Oosterom AT, Lohman PHM, Berens F. Cis-Diamminedichloroplatinum(II)-induced DNA adducts in peripheral leukocytes from seven cancer patients: quantitative immunochemical detection of the adduct induction and removal after a single dose of cis-diamminedichloroplatinum(II). Cancer Res 1987; 47: 3000-4.
20. 20. Farr CJ, Saiki RK, Ehrlich HA, McCormick F, Marshall CJ. Analysis of ras gene mutations in acute myeloid leukemia by polymerase chain reaction and oligonucleotide probes. Proc Natl Acad Sci USA 1988; 85: 1629-33.
21. 21. Dempke WCM, Shellard SA, Hosking LK, Fichtinger-Schepman AMJ, Hill BT. Mechanisms associated with the expression of cisplatin resistance in a human ovarian tumor cell line following exposure to fractionated X-irradiation in vitro. Carcinogenesis 1992; 13: 1209-15.
22. 22. Kalinowski DP, Illenye S, van Houten B. Analysis of DNA damage and repair in murine leukemia L1210 cells using a quantitative polymerase chain reaction assay. Nucleic Acids Res 1992; 20: 3485-94.
23. 23. Thorn JT, Todd AV, Croaker GM, Iland HJ. Characterization of K562 cells following introduction of a mutant N-ras gene. Leukemia Res 1993; 17: 23-9.
24. 24. Guo Z, Heydari AR, Wu W, Yang H, Sabia MR, Richardson A. Charaterization of gene-specific DNA repair by primary cultures of rat hepatocytes. J Cell Physiol 1998; 176: 314-22.
25. 25. Brandt TY, Osman F. Detection of DNA damage in transcriptionally active genes by RT-PCR and assessment of repair of cisplatin-induced damage in the glutathione S-transferase-pi gene in human glioblastoma cells. Toxicol Appl Pharmacol 1997; 143: 22-9.
26. 26. Madhani HD, Bohr VA, Hanwalt PC. Differential DNA repair in transcriptionally active and inactive protooncogenes: c-abl and c-mos. Cell 1986; 45: 417-26.
27. 27. Dong Q, Pieper RO, Erickson LC. Formation and disappearance of cis-Pt induced DNA interstrrand cross-links in the c-myc oncogene. Proc Am Ass Cancer Res 1991; 32: 408.
28. 28. Cobb MH, Goldsmith EJ. How MAP kinases are regulated. J Biol Chem 1995; 270: 14843-9.
29. 29. Milne DM, Campbell DG, Caudwell FB, Meek DW. Phosphorylation of the tumor suppressor protein p53 by mitogen-activated kinases. J Biol Chem 1994; 269: 9253-9.
30. 30. Yonish-Rouach E, Grunwald D, Wilder S, et al. p53-mediated cell death: relationship to cell cycle control. Mol Cell Biol 1993, 13: 1415-23.